Recent News Apr 3, 2025 aTyr Pharma to Participate in April Investor Conferences Mar 27, 2025 aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 26, 2025 aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise...
Other News Press Releases Piper Sandler Remains a Buy on aTyr Pharma (ATYR) Mar. 31, 2025 at 6:56 a.m. ET on TipRanks.com Confident Buy Rating for aTyr Pharma Amidst Promising Phase 3 Study Insights Mar. 27, 2025 at 7:26 a.m. ET on TipRanks.com aTyr names Dalia Reyes ...
Recent News MarketWatch Dow Jones No Headlines Available Other News Press Releases aTyr Pharma: Attractive Buy Opportunity Amid Positive Phase 2 Data and Anticipated Phase 3 Catalysts Mar. 7, 2025 at 9:45 a.m. ET on TipRanks.com Piper Sandler Remains a Buy on aTyr Pharma (ATYR) ...
aTyr Pharma is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Our lead therapeutic candidate is efzofitimod, a first-in-class biologic immunomodulator in clinical development for the treatment...
周五,H.C. Wainwright在aTyr Pharma(NASDAQ:ATYR)发布2024年第四季度和全年财务业绩后,重申了"买入"评级,目标价为35.00美元。财报显示,第四季度每股收益(EPS)为(-0.18)美元,全年为(-0.86)美元,均优于H.C. Wainwright预估的(-0.22)美元和(-0.90)美元,以及市场普遍预期的(-0.23)美元和(-0.91)美元。根据Investi...
周三,Freedom Broker对aTyr Pharma(NASDAQ:ATYR)启动研究覆盖,给予"买入"评级,目标价为$9.00,与分析师1.4的强烈买入共识一致。该公司的乐观预期基于公司强大的研发管线,特别强调了目前正在进行关键性三期临床试验的Efzofitimod的潜力。根据InvestingPro数据,分析师目标价区间为$9至$35,显示出相对当前价位具有显著上涨空间...
斯克利普斯研究院 Xiang-Lei Yang 副教授发表的研究进一步验证 aTyr Pharma 的专利药品发现引擎 圣迭戈2009年6月10日电 /美通社亚洲/ -- 斯克利普斯研究院(The Scripps Research Institute,简称 TSRI)2009年6月1日版的《News & Views》重点报道了来自副教授 Xiang-Lei Yang (杨湘磊) 研究室新近发表的研究。Xiang...
Customizable interactive chart for Atyr Pharma Inc with latest real-time price quote, charts, latest news, technical analysis and opinions.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/atyr-pharma-inc-announces-pricing-of-initial-public-offering-300079225.html SOURCE aTyr Pharma, Inc. Help employers find you! Check out all thejobsandpost your resume....
For more information, please visit http://www.atyrpharma.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are usually identified by the use of words s...